4523 Eisai
- 6545.0
- -4.0-0.06%
Eisai News
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average fell for the first time in 3 days, and Fast Rite was pushed down by about 49 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks at the time of closing 1 day ago was 44 stocks with price increases, 181 stocks with price drops, and 0 stocks unchanged. The Nikkei Average fell for the first time in 3 days. The forward market transaction was closed at 38189.54 yen (estimated turnover of 880 million shares), which was 216.12 yen lower (-0.56%) compared to the previous day. The US stock market fell on April 30. The Dow average depreciated by $570.17 (-1.49%) at $37815.92, and the Nasdaq depreciated by 325.26 points (-2.04%)
Nikkei average contribution ranking (advance closing) ~ The Nikkei Average rebounded, and TOEREC boosted by about 61 yen with 1 brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 26 days ago was 121 stocks with a price increase and 101 stocks with a price drop of 3 stocks unchanged. The Nikkei Average rebounded. The front-end transaction was closed at 37780.35 yen (estimated volume of 740 million shares), which was 151.87 yen higher (+0.40%) compared to the previous day. The US stock market declined on the 25th. The Dow average depreciated by 375.12 dollars (-0.98%) at 38085.80 dollars, and the NASDAQ depreciated 100.99 points (-0.64%) at 15611.
Brands that moved the day before part 1 Japan Aviation Electronics Industry, CUC, Metawater, etc.
<コード>Stock name closing price on the 25th ⇒ Hulic ＜3003＞ 1424.5 -63.5 1st quarter operating profit decreased 30.5% compared to the previous day. Marubeni Leasing ＜9763＞ 3065 +10924 financial results and dividend forecasts for the fiscal year ending March 31, 24 were revised upward. Ishizuka Nitro ＜5204＞ operating profit for the fiscal year ending 2682 -16525 is expected to decrease 54.2%. Daiichi Sankyo ＜4568＞ 4766 +37 share buying/cancellation with an upper limit of 2.87% of the number of issued shares. Business is growing but stock prices are sluggish. No. 1<
Movements to avoid risk due to concerns about the performance of Japanese and American companies
The Nikkei Average fell sharply. The transaction closed at 37628.48 yen (estimated turnover of 1.59 billion shares), which depreciated by 831.60 yen. Profit-taking sales took precedence from the reaction that had risen by over 900 yen the day before. Also, the fact that US Meta Platforms, which showed a sluggish earnings forecast, was plummeting overtime worsened investor sentiment, and performance unease of domestic high-tech companies was also alarmed, and the Nikkei Average remained soft throughout the day. The fact that US stock index futures continue to be soft also strengthens the buy-off attitude
The Nikkei Average depreciates by 803 yen, and aggressive purchases ahead of financial events are in the mood to forego
The Nikkei Average depreciated by 803 yen (as of 13:50). In terms of the Nikkei average contribution, First Rate ＜9983＞, East Elec ＜8035＞, Advantest ＜6857＞, etc. are top negative contributors, while Daiichi Sankyo ＜4568＞, Eisai ＜4523＞, Daikin ＜6367＞, etc. are top positive contributors. All industries have dropped in price in the sector. The mining industry, transportation equipment, electrical equipment, real estate industry, and precision equipment are at the top of the price drop rate. Is the Nikkei average in the low range
Front market [stocks that have moved, stocks that have been created]
*Japan Aviation Electronics Industry＜6807＞ 2548 +217 The profit forecast for the current fiscal year exceeds market expectations. *Ordinary income forecasts were revised upward due to large vacuum ＜6962＞ 827 +44 exchange margin recording, etc. *Are Capcom ＜9697＞ 2636 +73.5 evoJapan upcoming events also expected. *Is it a supply-demand factor, such as buybacks in the high price range of NIPPATS ＜5991＞ 1584 +44? *Eisai ＜4523＞ No. 6244 +155 Alzheimer's drug “Rekenbi”
The Nikkei Average later started at 683 yen depreciation, and Sakura, Mitsui E&S, etc. fell
[Nikkei Stock Average, TOPIX (table)] Nikkei Average; 37776.64; -683.44TOPIX; 2673.79; -36.94 [Backward Closer Overview] The Nikkei Average in the back was 37776.64 yen, 683.44 yen lower than the previous day, and started by slightly expanding the decline from the previous draw (37818.11 yen). Nikkei 225 futures during lunchtime are compatible in the range of 37770 yen to 37850 yen. The dollar and yen are 1 dollar = 155.40-50 yen and 20 yen from around 9:00 a.m.
Nikkei Average Contribution Ranking (advance closing) ~ The Nikkei Average fell drastically for the first time in 4 days, and Fast Rite was pushed down by about 126 yen per brand
The number of gains and falls of the Nikkei Average constituent stocks as of closing 25 days ago was 32 stocks with price increases, 193 stocks with price drops, and 0 stocks unchanged. The Nikkei Average fell sharply. The forward transaction was closed at 37818.11 yen (estimated turnover of 790 million shares), 641.97 yen lower (-1.67%) compared to the previous day. The US stock market was mixed on the 24th. The Dow average depreciated by 42.77 dollars (-0.11%) to 38460.92 dollars, and the Nasdaq rose 16.11 points (+ 0.10%) to 15712
3 points to pay attention to in the aftermath - stocks announced financial results have been sold and investor sentiment worsens
I would like to pay attention to the following 3 points in the late-day transaction on the 25th. ・The Nikkei Average fell drastically, and investor sentiment deteriorated due to sales of stocks announcing financial results · The dollar and yen were slightly higher in the 155 yen range; the top contributor to price drops was First Rate ＜9983＞, and the same 2nd place was Tokyo Electron ＜8035＞■The Nikkei Average fell drastically, stocks announced financial results were sold, and investor sentiment deteriorated, and the Nikkei Average fell drastically. 37818.11 yen (-1.67%) lower than the previous day (estimated turnover 790 million)
The Nikkei Average fell drastically, stocks announced financial results were sold, and investor sentiment worsened
The Nikkei Average fell sharply. The forward transaction was closed at 37818.11 yen (estimated turnover of 790 million shares), 641.97 yen lower (-1.67%) compared to the previous day. The US stock market was mixed on the 24th. The Dow average closed at 38460.92 dollars with a depreciation of 42.77 dollars (-0.11%), the Nasdaq closed at 15712.75 with a 16.11 point increase (+ 0.10%), and the S&P 500 closed at 5071.63 with a 1.08 point increase (+ 0.02%). Semiconductor manufacturer Te
Alzheimer's Drug Leqembi Finally Sees Sales Pickup -- WSJ
By Peter Loftus Sales of a groundbreaking new Alzheimers disease treatment from Eisai and Biogen are finally accelerating, after a sluggish launch last year. Biogen said Wednesday that the number of
Biogen Says Uptake for Alzheimer's Therapy Is Improving
Sales revenue (preliminary report) of the anti-amyloid beta protofibril antibody “Recembi”
2024/4/24 for printing Eisai Co., Ltd. (Headquarters: Tokyo; Representative Executive Officer and CEO: Haruo Naito) is announcing that global sales revenue for the fourth quarter of fiscal 2023 (2024/1/1/1-3/31) of the anti-amyloid beta protofibrils antibody “Recembi” was 2.83 billion yen (pre-audit value), which was approximately 2.7 times higher than the previous quarter (2023/10/1 to 12/31). This information is from today's Biogen Ink (headquarters:
Unexpected! The promotion of the first FDA-approved Alzheimer's disease drug in the US is bad
① The doctors said their hesitation in prescribing Leqembi was due to concerns about the effects, costs, and risks of the drug; ② The two companies had hoped to treat 10,000 Americans by the end of March, but by the end of January, only a few thousand people had begun treatment with Leqembi.
Nikkei Average Contribution Ranking (big draw) ~ The Nikkei Average rebounded drastically, boosted by about 117 yen for the 2 brands Fast Rette and FANUC
The number of gains and falls of the Nikkei Average constituent stocks at the time of the big closing on the 22nd was 196 stocks with price increases, 28 stocks with price drops, and 1 stock unchanged. The US stock market was mixed over the weekend. The Dow average closed at 37986.40 dollars, which was 211.02 dollars higher (+0.56%), the Nasdaq was 319.49 points lower (-2.05%) at 15282.01, and the S&P 500 closed at 4967.23 with a 43.89 point drop (-0.88%). Regulations that limited Israel's retaliatory attacks against Iran
BioArctic And Eisai Collaborate On Evaluating BAN2802 For Alzheimer's Disease
Risk avoidance movements are intensifying as a reflection of the tense situation in the Middle East
The Nikkei Average fell sharply. The transaction closed at 3768.35 yen (estimated turnover of 2.16 billion shares), which depreciated by 1011.35 yen. The decline was the biggest this year. The trend where high-tech stocks were sold in the US market the day before spread, and the Nikkei Average began to fall. After that, risk aversion movements became even stronger in the middle of the front market, triggered by reports about the tense situation in the Middle East, and the Nikkei Average widened its decline until the previous closing, and it fell to 36733.06 yen, and during trading hours since 2/9, it was about 2
Nikkei average contribution ranking (advance closing) ~ The Nikkei average rebounded for the first time in 4 days, and Advantest boosted by about 57 yen with 1 brand
The number of gains and falls of the Nikkei Average constituent stocks at the time of closing 18 days ago was 187 stocks with price increases, 38 stocks with price drops, and 0 stocks unchanged. The Nikkei Average rebounded for the first time in 4 days. The front-end transaction was closed at 38090.87 yen (estimated turnover of 760 million shares), which is 129.07 yen higher (+0.34%) compared to the previous day. The US market declined on the 17th. The Dow average depreciated by $45.66 (-0.12%) to $37753.31, and the Nasdaq depreciated 181.88 points (-1.15%) to 15683
Biogen's Alzheimer's Drug to Cost $3.5B for Medicare in 2025: Report
Received the Reiwa 6th Minister of Education, Culture, Sports, Science and Technology Award for “research on therapeutic agents based on pathomechanisms of Alzheimer's disease” (research category) in the field of science and technology
For printing 2024/4/17, I would like to inform you that Eisai Co., Ltd. (Headquarters: Tokyo; Representative Executive Officer and CEO: Haruo Naito) has now received the Reiwa 6th Minister of Education, Culture, Sports, Science and Technology's Commendation Science and Technology Award (research category) in the field of science and technology for “research on therapeutic agents based on the pathomechanism of Alzheimer's disease.” The Ministry of Education, Culture, Sports, Science and Technology honors those who have achieved remarkable results in research and development and promotion of understanding related to science and technology as the “Minister of Education, Culture, Sports, Science and Technology's Commendation in the Field of Science and Technology.”
Analysis
Price Target
No Data
